HIV-2 EU—Supporting Standardized HIV-2 Drug Resistance Interpretation: An Update

Charlotte Charpentier; Dirk Berzow; Quentin Le Hingrat; Rolf Kaiser; Perpetua Gomes; Ana Claudia Miranda; Florence Damond; Jade Ghosn; Jeroen J A van Kampen; Björn-Erik Ole Jensen; Michael Böhm; Annemarie M J Wensing; Diane Descamps; Martin Obermeier

doi:10.1093/cid/ciaf110

HIV-2 EU—Supporting Standardized HIV-2 Drug Resistance Interpretation: An Update

Charlotte Charpentier^*
, Dirk Berzow
, Quentin Le Hingrat^*
, Rolf Kaiser
, Perpetua Gomes
, Ana Claudia Miranda
, Florence Damond
, Jade Ghosn
, Jeroen J A van Kampen
, Björn-Erik Ole Jensen
, Michael Böhm
, Annemarie M J Wensing
, Diane Descamps
, Martin Obermeier

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

1 Downloads (Pure)

Abstract

Human immunodeficiency virus type 2 (HIV-2) is an attenuated retroviral infection characterized by specific natural susceptibility to antiretroviral drugs and acquired resistance profiles. Based on the latest knowledge of phenotypic data and clinical follow-up, HIV-2 resistance interpretation rules have been updated and implemented in a freely available resistance analysis tool.

Original language	English
Pages (from-to)	539-542
Number of pages	4
Journal	Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Volume	81
Issue number	3
DOIs	https://doi.org/10.1093/cid/ciaf110
Publication status	Published - 15 Sept 2025

Keywords

HIV-2
Internet tool
drug-resistance rules
update

Access to Document

10.1093/cid/ciaf110

ciaf110Final published version, 391 KBLicence: Taverne

Cite this

Charpentier, C., Berzow, D., Le Hingrat, Q., Kaiser, R., Gomes, P., Miranda, A. C., Damond, F., Ghosn, J., van Kampen, J. J. A., Jensen, B.-E. O., Böhm, M., Wensing, A. M. J., Descamps, D., & Obermeier, M. (2025). HIV-2 EU—Supporting Standardized HIV-2 Drug Resistance Interpretation: An Update. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 81(3), 539-542. https://doi.org/10.1093/cid/ciaf110

@article{c32d5d42bb4b40dcb089d5d05affecf0,

title = "HIV-2 EU—Supporting Standardized HIV-2 Drug Resistance Interpretation: An Update",

abstract = "Human immunodeficiency virus type 2 (HIV-2) is an attenuated retroviral infection characterized by specific natural susceptibility to antiretroviral drugs and acquired resistance profiles. Based on the latest knowledge of phenotypic data and clinical follow-up, HIV-2 resistance interpretation rules have been updated and implemented in a freely available resistance analysis tool.",

keywords = "HIV-2, Internet tool, drug-resistance rules, update",

author = "Charlotte Charpentier and Dirk Berzow and \{Le Hingrat\}, Quentin and Rolf Kaiser and Perpetua Gomes and Miranda, \{Ana Claudia\} and Florence Damond and Jade Ghosn and \{van Kampen\}, \{Jeroen J A\} and Jensen, \{Bj{\"o}rn-Erik Ole\} and Michael B{\"o}hm and Wensing, \{Annemarie M J\} and Diane Descamps and Martin Obermeier",

year = "2025",

month = sep,

day = "15",

doi = "10.1093/cid/ciaf110",

language = "English",

volume = "81",

pages = "539--542",

journal = "Clinical infectious diseases : an official publication of the Infectious Diseases Society of America",

issn = "1058-4838",

publisher = "Oxford University Press",

number = "3",

}

Charpentier, C, Berzow, D, Le Hingrat, Q, Kaiser, R, Gomes, P, Miranda, AC, Damond, F, Ghosn, J, van Kampen, JJA, Jensen, B-EO, Böhm, M, Wensing, AMJ, Descamps, D & Obermeier, M 2025, 'HIV-2 EU—Supporting Standardized HIV-2 Drug Resistance Interpretation: An Update', Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol. 81, no. 3, pp. 539-542. https://doi.org/10.1093/cid/ciaf110

HIV-2 EU—Supporting Standardized HIV-2 Drug Resistance Interpretation: An Update. / Charpentier, Charlotte; Berzow, Dirk; Le Hingrat, Quentin et al.
In: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 81, No. 3, 15.09.2025, p. 539-542.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - HIV-2 EU—Supporting Standardized HIV-2 Drug Resistance Interpretation

T2 - An Update

AU - Charpentier, Charlotte

AU - Berzow, Dirk

AU - Le Hingrat, Quentin

AU - Kaiser, Rolf

AU - Gomes, Perpetua

AU - Miranda, Ana Claudia

AU - Damond, Florence

AU - Ghosn, Jade

AU - van Kampen, Jeroen J A

AU - Jensen, Björn-Erik Ole

AU - Böhm, Michael

AU - Wensing, Annemarie M J

AU - Descamps, Diane

AU - Obermeier, Martin

PY - 2025/9/15

Y1 - 2025/9/15

N2 - Human immunodeficiency virus type 2 (HIV-2) is an attenuated retroviral infection characterized by specific natural susceptibility to antiretroviral drugs and acquired resistance profiles. Based on the latest knowledge of phenotypic data and clinical follow-up, HIV-2 resistance interpretation rules have been updated and implemented in a freely available resistance analysis tool.

AB - Human immunodeficiency virus type 2 (HIV-2) is an attenuated retroviral infection characterized by specific natural susceptibility to antiretroviral drugs and acquired resistance profiles. Based on the latest knowledge of phenotypic data and clinical follow-up, HIV-2 resistance interpretation rules have been updated and implemented in a freely available resistance analysis tool.

KW - HIV-2

KW - Internet tool

KW - drug-resistance rules

KW - update

UR - https://www.scopus.com/pages/publications/105017914519

U2 - 10.1093/cid/ciaf110

DO - 10.1093/cid/ciaf110

M3 - Article

C2 - 40071658

SN - 1058-4838

VL - 81

SP - 539

EP - 542

JO - Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

JF - Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

IS - 3

ER -

HIV-2 EU—Supporting Standardized HIV-2 Drug Resistance Interpretation: An Update

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this